Investigating the Mechanisms of Decision-Making Using Non-Invasive Brain Stimulation

NCT07749378 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-08-06

No results posted yet for this study

Summary

This study aims to investigate which of two brain regions is important for which decision-making strategy. The investigators suppose that one brain region - the \*striatum\* - is important for repeatedly choosing objects that have previously been paired with rewards (strategy 1). They suppose that a different region - the \*hippocampus\* - is important for extending such reasoning to RELATED objects (strategy 2).

The investigators will repeatedly ask young and healthy subjects to choose between two objects. The two objects are repeatedly drawn from a pool of seven. Relations between the seven objects have been learned on the first day of the experiment. The investigators will record subjects' choices and will use an automated way to assess the extent to which any given subject uses either decision-making strategy.

* On one day, subjects will perform the task while their right hippocampus is being stimulated with non-invasive electrical stimulation ("condition A").
* On another day, subjects will perform the same task but with their striatum being stimulated ("condition B").
* On yet another day, a control stimulation ("condition C") will be applied that looks and feels like the real stimulation but does not influence brain activity.

Which stimulation (A, B, C) happens on which day is assigned by computer code and differs between subjects. Subjects do not know, and investigators mostly do not know, whether real or control stimulation is applied on each day.

The investigators will check whether subjects use strategy 1 more when their striatum is being stimulated and strategy 2 more when their hippocampus is being stimulated, as compared to when the control stimulation is applied.

Conditions

  • Young Healthy Adults

Interventions

DEVICE

Hippocampal intermittent-theta burst stimulation

Transcranial temporal interference stimulation using intermittent theta-burst protocol and targeting right hippocampus. Unlike the striatal set-up, the hippocampal electrode set-up is asymmetrical and can only stimulate unilaterally (Beanato, Moon et al., 2024; Violante et al., 2023). In the present study, \*right\* hippocampus is targeted because it showed cognitive map-compatible activity in a similar task in a previous study (Garvert et al., 2023) and because it has been suggested to be involved in map-based navigation (Iglói et al., 2010).

DEVICE

Striatal intermittent-theta burst stimulation

Transcranial temporal interference stimulation using intermittent theta-burst protocol and targeting bilateral striatum.

DEVICE

High-frequency control stimulation with striatal electrode set-up

Analoguous to transcranial temporal interference stimulation except both high-frequency electric fields are oscillating at the exact same frequency, meaning there is no biologically active envelope modulation. This high-frequency stimulation is applied with the striatal electrode set-up in 50 % of the subjects (hippocampal set-up in the other 50 %). No stimulation actually occurs because the stimulation frequency is too high to be biologically active (Grossman et al., 2017).

DEVICE

High-frequency control stimulation with hippocampal electrode set-up

Analoguous to transcranial temporal interference stimulation except both high-frequency electric fields are oscillating at the exact same frequency, meaning there is no biologically active envelope modulation. This high-frequency stimulation is applied with the hippocampal electrode set-up in 50 % of the subjects (striatal set-up in the other 50 %). No stimulation actually occurs because the stimulation frequency is too high to be biologically active (Grossman et al., 2017).

Sponsors & Collaborators

  • University of Wuerzburg

    collaborator OTHER
  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Maximilian J. Wessel, Prof. Dr. · University Hospital Würzburg (UKW)

  • Mona M. Garvert, Prof. Dr. · Julius-Maximilians-Universität Würzburg (JMU)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-27
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07749378 on ClinicalTrials.gov